logo

For the Inventor, By the Inventor

Tokyo, Japan

Hiroyoshi Horikoshi

USPTO Granted Patents = 30 

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 270(Granted Patents)


Location History:

  • Hiromachi, JP (1989 - 1990)
  • Kobe, JP (1998)
  • Tokyo, JP (1980 - 2000)
  • Funabashi, JP (1998 - 2002)

Company Filing History:

goldMedal30 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1980-2002

Loading Chart...
30 patents (USPTO):Explore Patents
1. 6353009 - Method for the treatment and prevention of hyperuricemia (2002-03-05),
2. 6159997 - Treatment of arteriosclerosis and xanthoma (2000-12-12),
3. 6150371 - Method for preventing and for treating autoimmune disease (2000-11-21),
4. 6117893 - Heterocyclic compounds having anti-diabetic activity and their use (2000-09-12),
5. 5977365 - Heterocyclic compound having anti-diabetic activity (1999-11-02),
6. 5972959 - Oxime derivatives, their preparation and their therapeutic use (1999-10-26),
7. 5962470 - Heterocyclic compounds having anti-diabetic activity and their use (1999-10-05),
8. 5886014 - Benzimidazole derivatives, their preparation and their therapeutic use (1999-03-23),
9. 5834501 - Heterocyclic compounds having anti-diabetic activity and their use (1998-11-10),
10. 5804590 - Treatment and prophylaxis of osteoporosis (1998-09-08),
11. 5798375 - Treatment of arteriosclerosis and xanthoma (1998-08-25),
12. 5780490 - Oxime derivatives, their preparation and their therapeutic use (1998-07-14),
13. 5760025 - Steroid derivatives for the treatment of prostatic hypertrophy, their (1998-06-02),
14. 5753681 - Treatment and prophylaxis of pancreatitis (1998-05-19),
15. 5739345 - Intermediate compounds in the preparation of heterocyclic compounds (1998-04-14),

Title: Hiroyoshi Horikoshi: A Pioneer in Pharmaceutical Innovations

Introduction

Hiroyoshi Horikoshi is a distinguished inventor based in Tokyo, Japan, known for his notable contributions to the pharmaceutical industry. With a total of 30 patents to his name, he has made significant advancements in the treatment of various metabolic disorders.

Latest Patents

Among his latest innovations, Horikoshi has developed a method for the treatment and prevention of hyperuricemia. This invention highlights the utility of insulin sensitivity enhancers, such as troglitazone, in addressing conditions like gout, urinary calculus, hyperuricemic nephropathy, and Lesch-Nyhan syndrome. Another remarkable patent focuses on the treatment of arteriosclerosis and xanthoma, which combines the effectiveness of HMG-CoA reductase inhibitors with insulin sensitizers. This synergistic approach demonstrates a significantly improved efficacy in preventing and treating these conditions compared to individual components.

Career Highlights

Throughout his career, Horikoshi has been an integral part of Sankyo Company, Limited, where his work has been pivotal in fostering innovation and improving healthcare outcomes. His research has had a lasting impact on the understanding and management of complex metabolic diseases.

Collaborations

Horikoshi has collaborated with various esteemed professionals in his field, including Takao Yoshioka and Toshihiko Fujiwara. These collaborations have enhanced the breadth and depth of his research, leading to innovative solutions that benefit patients worldwide.

Conclusion

Hiroyoshi Horikoshi’s extensive patent portfolio and his ongoing contributions to pharmaceutical innovations underscore his role as a key figure in modern medicine. His dedication to finding effective treatments for challenging medical conditions continues to inspire and pave the way for future advancements in health science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…